RxSight, Inc. will present at the Bank of America Healthcare Conference on May 14, 2025, in Las Vegas.
Quiver AI Summary
RxSight, Inc., a company focused on innovative ophthalmic medical devices, announced its participation in the Bank of America Healthcare Conference in Las Vegas, where its management will present on May 14, 2025, at 3:40 p.m. PT. The presentation will be available via a live and archived webcast for interested viewers. RxSight is known for its Light Adjustable Lens system, which is the only intraocular lens technology that can be adjusted post-surgery, allowing for personalized vision solutions for cataract surgery patients. Further information about the company and its products is available on their website.
Potential Positives
- RxSight is participating in the Bank of America Healthcare Conference, which can enhance visibility and credibility in the healthcare sector.
- The scheduled presentation indicates strong management engagement with investors and stakeholders, potentially increasing investor interest.
- The RxSight Light Adjustable Lens system is highlighted as a unique and innovative product in the ophthalmic market, underscoring the company's commitment to advancing cataract surgery outcomes.
Potential Negatives
- e
FAQ
What event is RxSight participating in?
RxSight is participating in the Bank of America Healthcare Conference in Las Vegas.
When will RxSight's presentation take place?
RxSight's presentation is scheduled for Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time.
How can I access RxSight's presentation?
The presentation can be accessed via a live and archived webcast at https://investors.rxsight.com/.
What is the RxSight Light Adjustable Lens system?
The RxSight Light Adjustable Lens system allows doctors to customize vision post-cataract surgery using adjustable intraocular lens technology.
Where can I find more information about RxSight?
Additional information about RxSight can be found at www.rxsight.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$RXST Insider Trading Activity
$RXST insiders have traded $RXST stock on the open market 21 times in the past 6 months. Of those trades, 6 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $RXST stock by insiders over the last 6 months:
- ILYA GOLDSHLEGER (See remarks) has made 0 purchases and 12 sales selling 27,915 shares for an estimated $1,339,827.
- JESSE ANDERSON CORLEY has made 6 purchases buying 25,686 shares for an estimated $1,114,574 and 0 sales.
- SHWETA MANIAR has made 0 purchases and 2 sales selling 7,301 shares for an estimated $282,136.
- TAMARA FOUNTAIN sold 7,000 shares for an estimated $180,001
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXST Hedge Fund Activity
We have seen 113 institutional investors add shares of $RXST stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LORD, ABBETT & CO. LLC removed 1,049,822 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $36,092,880
- CITADEL ADVISORS LLC added 782,424 shares (+369.5%) to their portfolio in Q4 2024, for an estimated $26,899,737
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC removed 687,711 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $23,643,504
- INVESCO LTD. removed 596,434 shares (-60.4%) from their portfolio in Q4 2024, for an estimated $20,505,400
- CREDIT AGRICOLE S A added 592,031 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,354,025
- ROYAL BANK OF CANADA added 492,574 shares (+3094.6%) to their portfolio in Q4 2024, for an estimated $16,934,694
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 472,349 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $16,239,358
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference in Las Vegas.
RxSight’s management is scheduled to present on Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/ .
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight ® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens ® (LAL ® /LAL+ ® ), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com .
Company Contact:
Shelley B. Thunen
Chief Financial Officer
[email protected]
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
[email protected]
